Andreu J M, Perez-Ramirez B, Gorbunoff M J, Ayala D, Timasheff S N
Department of Biochemistry, Brandeis University, Waltham, Massachusetts 02254-9110, USA.
Biochemistry. 1998 Jun 9;37(23):8356-68. doi: 10.1021/bi9728553.
The roles of the methoxy substituents on ring A of two ring colchicine (COL) analogues were probed by the synthesis of a number of drugs and the examination of their effect on binding to tubulin, inhibition of microtubule assembly, and induction of GTPase activity. Selective elimination of ring A methoxy groups at positions 2, 3, and 4 weakened all three processes. The effects on binding and inhibition were independent of the nature of ring C (or C'). Specifically, excision of the 2- or 3-methoxy groups weakened binding by ca. 0.4 kcal mol-1, while that of the 4-methoxy group of ring A was weakened by 1.36 +/- 0.15 kcal mol-1. The effect on the inhibition of microtubule assembly, expressed as the equilibrium constant for the binding of the tubulin-drug complex to the end of a microtubule, was more complex and strongly dependent on the nature of ring C (or C'). This was attributed to the abilities of various groups on ring C' to overcome the wobbling in the tubulin-drug complex introduced by the weakening of the anchoring provided by ring A. It is concluded that ring A of COL is not germane to the mechanism of the inhibition of tubulin self-assembly. It serves only as a complex-stabilizing anchor. The control of this process resides in the interactions that key oxygen atoms of ring C of COL or C' of structural analogues establish with the protein. It is proposed that the 4-methoxy group of ring A serves as a key attachment point for immobilization of the drugs on the protein.
通过合成多种药物并检测它们对与微管蛋白结合、抑制微管组装以及诱导GTP酶活性的影响,探究了两种环秋水仙碱(COL)类似物A环上甲氧基取代基的作用。选择性去除A环2、3和4位的甲氧基会削弱所有这三个过程。对结合和抑制的影响与C环(或C'环)的性质无关。具体而言,切除2-或3-甲氧基会使结合力减弱约0.4千卡/摩尔,而A环4-甲氧基的结合力减弱1.36±0.15千卡/摩尔。对微管组装抑制的影响,以微管蛋白-药物复合物与微管末端结合的平衡常数表示,更为复杂且强烈依赖于C环(或C'环)的性质。这归因于C'环上各种基团克服由A环提供的锚定减弱所引入的微管蛋白-药物复合物中摆动的能力。得出的结论是,COL的A环与微管蛋白自组装抑制机制无关。它仅作为一个稳定复合物的锚定基团。该过程的控制在于COL的C环或结构类似物的C'环的关键氧原子与蛋白质之间的相互作用。有人提出,A环的4-甲氧基作为药物固定在蛋白质上的关键附着点。